Aequus Reports Third Quarter 2022 Financial Highlights
29 nov. 2022 20h21 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Announces Sandoz Contract Expiry at Year End and Expected Health Canada Approval for Zimed® PF (Preservative Free)
29 nov. 2022 08h00 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), announced today that it has agreed to end its...
Aequus Reports Second Quarter 2022 Financial Highlights and General Update
29 août 2022 19h49 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Press Release for Early Warning Report Regarding Aequus Pharmaceuticals Inc.
23 juil. 2022 00h09 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, July 23, 2022 (GLOBE NEWSWIRE) -- Doug Janzen, of 2820 – 200 Granville St., Vancouver, BC, V6C 1S4, today announced that on Tuesday, July 19, 2022, he acquired ownership...
Aequus Resumes Trading on TSX Venture Exchange
13 juil. 2022 16h00 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) announces that further to our news release dated July 6, 2022, we will resume...
Aequus Signs Exclusive Distribution Agreement with SCOPE Ophthalmics for Canadian Distribution Rights of Dry Eye Products
06 juil. 2022 18h23 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, July 06, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”) is pleased to announce the signing of an exclusive...
Aequus Provides General Update and Reports Record 2021 Financial Results
01 juil. 2022 17h51 HE
|
Aequus Pharmaceuticals
Also reports Financial Results for the 3 months ended March 31, 2022 VANCOUVER, British Columbia, July 01, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF)...
Aequus Provides Update on Delay in Filing Annual Financial Statements
13 juin 2022 09h00 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, June 13, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”) announces that further to its news release on May 6,...
Aequus Provides Update on Delay in Filing Annual Financial Statements
27 mai 2022 08h00 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, May 27, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”) announces that further to its news release on May 6,...
Aequus Provides Update on Delay in Filing Annual Financial Statements
06 mai 2022 19h30 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, May 06, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”) announces that further to its news release on May 2,...